Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-09, Vol.28, p.v88-v88 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v88 |
|---|---|
| container_issue | |
| container_start_page | v88 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Sabatier, R. Meskine, A. Cappiello, M.A. Extra, J-M. Tarpin, C. Rousseau, F. Provansal, M. Bertucci, F. Viens, P. Gonçalves, A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx365.033 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx365_033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420376948</els_id><sourcerecordid>S0923753420376948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1853-6db5a83747035c949d8077a8db7bf05b4b5e9d6de272316073469f87218a0e5b3</originalsourceid><addsrcrecordid>eNp9kNFKwzAUhoMoOKcP4F1eoFvSNE2DVzKmEwaCuOuSJqcusiYlidO9hk9sS3ft1TkH_u9wzofQPSULSiRbKue808vO_LCSLwhjF2hGeSmzihT0Es2IzFkmOCuu0U2Mn4SQUuZyhn53LgVQCQze-9B5BziAhj75gHsfbbJHWG7Wb3nm4EONE-4gqZiGXuNmQGPCWjkNAcevcLRHdcDfNu1xG7xL2cEOG_UeOp_2EFR_wsoZ3CnrErgRw-CM12GMnRO36KpVhwh35zpHu6f1-2qTbV-fX1aP20zTirOsNA1XFROFIIxrWUhTESFUZRrRtIQ3RcNBmtJALnJGSyJYUcq2EjmtFAHesDmi014dfIwB2roPtlPhVFNSj1LrSWo9Sa0HqQPzMDEwHHa0EOqoLQxvGDtoS7Xx9h_6DyushjI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Sabatier, R. ; Meskine, A. ; Cappiello, M.A. ; Extra, J-M. ; Tarpin, C. ; Rousseau, F. ; Provansal, M. ; Bertucci, F. ; Viens, P. ; Gonçalves, A.</creator><creatorcontrib>Sabatier, R. ; Meskine, A. ; Cappiello, M.A. ; Extra, J-M. ; Tarpin, C. ; Rousseau, F. ; Provansal, M. ; Bertucci, F. ; Viens, P. ; Gonçalves, A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx365.033</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-09, Vol.28, p.v88-v88</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1853-6db5a83747035c949d8077a8db7bf05b4b5e9d6de272316073469f87218a0e5b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Sabatier, R.</creatorcontrib><creatorcontrib>Meskine, A.</creatorcontrib><creatorcontrib>Cappiello, M.A.</creatorcontrib><creatorcontrib>Extra, J-M.</creatorcontrib><creatorcontrib>Tarpin, C.</creatorcontrib><creatorcontrib>Rousseau, F.</creatorcontrib><creatorcontrib>Provansal, M.</creatorcontrib><creatorcontrib>Bertucci, F.</creatorcontrib><creatorcontrib>Viens, P.</creatorcontrib><creatorcontrib>Gonçalves, A.</creatorcontrib><title>Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kNFKwzAUhoMoOKcP4F1eoFvSNE2DVzKmEwaCuOuSJqcusiYlidO9hk9sS3ft1TkH_u9wzofQPSULSiRbKue808vO_LCSLwhjF2hGeSmzihT0Es2IzFkmOCuu0U2Mn4SQUuZyhn53LgVQCQze-9B5BziAhj75gHsfbbJHWG7Wb3nm4EONE-4gqZiGXuNmQGPCWjkNAcevcLRHdcDfNu1xG7xL2cEOG_UeOp_2EFR_wsoZ3CnrErgRw-CM12GMnRO36KpVhwh35zpHu6f1-2qTbV-fX1aP20zTirOsNA1XFROFIIxrWUhTESFUZRrRtIQ3RcNBmtJALnJGSyJYUcq2EjmtFAHesDmi014dfIwB2roPtlPhVFNSj1LrSWo9Sa0HqQPzMDEwHHa0EOqoLQxvGDtoS7Xx9h_6DyushjI</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Sabatier, R.</creator><creator>Meskine, A.</creator><creator>Cappiello, M.A.</creator><creator>Extra, J-M.</creator><creator>Tarpin, C.</creator><creator>Rousseau, F.</creator><creator>Provansal, M.</creator><creator>Bertucci, F.</creator><creator>Viens, P.</creator><creator>Gonçalves, A.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy</title><author>Sabatier, R. ; Meskine, A. ; Cappiello, M.A. ; Extra, J-M. ; Tarpin, C. ; Rousseau, F. ; Provansal, M. ; Bertucci, F. ; Viens, P. ; Gonçalves, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1853-6db5a83747035c949d8077a8db7bf05b4b5e9d6de272316073469f87218a0e5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sabatier, R.</creatorcontrib><creatorcontrib>Meskine, A.</creatorcontrib><creatorcontrib>Cappiello, M.A.</creatorcontrib><creatorcontrib>Extra, J-M.</creatorcontrib><creatorcontrib>Tarpin, C.</creatorcontrib><creatorcontrib>Rousseau, F.</creatorcontrib><creatorcontrib>Provansal, M.</creatorcontrib><creatorcontrib>Bertucci, F.</creatorcontrib><creatorcontrib>Viens, P.</creatorcontrib><creatorcontrib>Gonçalves, A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sabatier, R.</au><au>Meskine, A.</au><au>Cappiello, M.A.</au><au>Extra, J-M.</au><au>Tarpin, C.</au><au>Rousseau, F.</au><au>Provansal, M.</au><au>Bertucci, F.</au><au>Viens, P.</au><au>Gonçalves, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v88</spage><epage>v88</epage><pages>v88-v88</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx365.033</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-09, Vol.28, p.v88-v88 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx365_033 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A49%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Untreated%20hormone%20receptor%20positive/HER2-negative%20metastatic%20breast%20cancer%20survival%20with%20front-line%20chemotherapy%20and%20maintenance%20endocrine%20therapy&rft.jtitle=Annals%20of%20oncology&rft.au=Sabatier,%20R.&rft.date=2017-09&rft.volume=28&rft.spage=v88&rft.epage=v88&rft.pages=v88-v88&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx365.033&rft_dat=%3Celsevier_cross%3ES0923753420376948%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420376948&rfr_iscdi=true |